Under terms of the deal, Novartis will give Epistem a $4 million upfront payment and provide funding to study the stem cell shop's drug targets. Epistem could also get up to $45 million in milestone payments for each product developed from targets licensed under the agreement.
HHMI and University of Washington researcher Evan Eichler led a team of researchers who found evidence suggesting a gene called IRGM became a pseudogene in the ancestor of monkeys and apes before being resurrected in the human-great ape lineage.
Using gene expression and copy number analyses of dozens of endometrial cancers, an international research team has turned up characteristic expression profiles and gene amplifications linked to poor outcomes.
For Agilent, the debut of SurePrint G3 caps a year of upgrading its microarray platform. The density upgrade also comes at a time when all other major array companies have made similar improvements with their platforms.